Author Archive

The African Markets Pharma Can’t Ignore

Julian Upton Pharm Exec EuropeIn its new study on pharma market growth in Africa, IMS Health highlights three ‘rising star’ countries from the continent’s sub-Saharan region. Read more »

Study ‘Confirms Economic Viability’ of Orphan Drugs

Julian Upton Pharm Exec EuropeOrphan drugs achieved blockbuster status in 2011, generating over $50 billion, and have the potential to generate as much lifetime revenue as drugs used for more common health conditions, according to a report from Thomson Reuters’ IP & Science division. Read more »

Pfizer Site Closure “Shocking Wake-Up Call” for UK

Julian Upton Pharm Exec EuropeIt’s not too often that a pharma facility closure tops the TV news headlines but that was the case in the UK this week following Pfizer’s announcement that it is to close the UK-based R&D centre that achieved worldwide fame as “the home of Viagra”. Read more »

How Cloud Computing Is Aiding Pharma

Julian Upton Pharm Exec EuropeRecently, I spoke to R. Arun Kumar about the wider applications of cloud computing. Arun Kumar is Vice President and Head of the Global Life Sciences Business Unit at Infosys, an IT, business consulting and outsourcing services provider. Read more »

Nycomed: A(PI) Passage to India

Julian Upton Pharm Exec EuropeIn a move that has both provided a vote of confidence for an emerging market’s manufacturing capabilities and underlined Western pharma’s increasing reliance on lower cost production alternatives, Nycomed’s plan to relocate its entire Pantrazole API production from two plants in Europe to India recently reached fruition with the inauguration of their extended facility at Navi Mumbai. Read more »

Pharma Is Over the Social Media Hump. Now What?

Julian Upton Pharm Exec EuropeSo, pharma is — arguably — “over the social media hump.” Everyone now “wants to do it”. But how does pharma do it? How can companies successfully use social media to market their messages and their products? That’s the question addressed in Pharm Exec’s new episode of Pharma Faceoff, chaired by Barbara Ryan of Deutsche Bank. Read more »

Do You Have A Head of Social Media?

Julian Upton Pharm Exec EuropeIf anyone had any lingering doubts about an unprecedented era of inclusion and transparency promised by pharma’s newfound, if tentative, embrace of online social media, then last month’s Digital Pharma Europe conference must have gone some way to soothing them. Here, Novartis companionably took the stage with Boehringer-Ingelheim, Roche sat happily alongside AstraZeneca, and they all — along with representatives from other rival companies — were warmly welcomed into the Bayer-Schering headquarters in Berlin to swap stories, explain strategies and generally offer each other support and advice with regard to the latest phenomenon in pharma communications. Indeed, if I was less cynical a person, such a display of harmony and co-operation might have brought a tear to my eye. Read more »

Regulatory Affairs: Challenges for 2010

Julian Upton Pharm Exec EuropeThe Organization for Professionals in Regulatory Affairs (TOPRA) is a non-profit, non-political organization that seeks to advance the status of the regulatory profession through education and the provision of information to its members. Its members are drawn from industry, regulatory agencies and consultancies from over 40 countries. Pharm. Exec. Europe (PEE) spoke to TOPRA’s president-elect, Dr Zubair Hussain, head of regulatory affairs for Pfizer UK and Ireland, about what he sees as pharma’s key regulatory challenges for 2010 and beyond. Read more »